| Product Code: ETC7907570 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Chronic Hepatitis B (CHB) Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Chronic Hepatitis B (CHB) Market - Industry Life Cycle |
3.4 Latvia Chronic Hepatitis B (CHB) Market - Porter's Five Forces |
3.5 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.7 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Chronic Hepatitis B (CHB) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about chronic hepatitis B in Latvia |
4.2.2 Advancements in medical technology for CHB treatment |
4.2.3 Growing healthcare expenditure in Latvia |
4.3 Market Restraints |
4.3.1 High treatment costs for chronic hepatitis B |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Latvia |
5 Latvia Chronic Hepatitis B (CHB) Market Trends |
6 Latvia Chronic Hepatitis B (CHB) Market, By Types |
6.1 Latvia Chronic Hepatitis B (CHB) Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.1.4 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Immune Modulators, 2021- 2031F |
6.2 Latvia Chronic Hepatitis B (CHB) Market, By Gender |
6.2.1 Overview and Analysis |
6.2.2 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Male, 2021- 2031F |
6.2.3 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Female, 2021- 2031F |
6.3 Latvia Chronic Hepatitis B (CHB) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 Latvia Chronic Hepatitis B (CHB) Market Revenues & Volume, By Online Providers, 2021- 2031F |
7 Latvia Chronic Hepatitis B (CHB) Market Import-Export Trade Statistics |
7.1 Latvia Chronic Hepatitis B (CHB) Market Export to Major Countries |
7.2 Latvia Chronic Hepatitis B (CHB) Market Imports from Major Countries |
8 Latvia Chronic Hepatitis B (CHB) Market Key Performance Indicators |
8.1 Number of patients diagnosed with CHB annually |
8.2 Percentage of CHB patients receiving appropriate treatment |
8.3 Rate of adoption of new CHB treatment protocols |
9 Latvia Chronic Hepatitis B (CHB) Market - Opportunity Assessment |
9.1 Latvia Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Latvia Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Gender, 2021 & 2031F |
9.3 Latvia Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Chronic Hepatitis B (CHB) Market - Competitive Landscape |
10.1 Latvia Chronic Hepatitis B (CHB) Market Revenue Share, By Companies, 2024 |
10.2 Latvia Chronic Hepatitis B (CHB) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here